Microencapsulated VEGF gene-modified umbilical cord mesenchymal stromal cells promote the vascularization of tissue-engineered dermis: An experimental study

Cytotherapy

Volumn 16, Issue 2, 2014, Pages 160-169

  Han, Yanfu ^a,b   Tao, Ran ^b   Han, Yanqing ^c   Sun, Tianjun ^b   Chai, Jiake ^b   Xu, Guang ^a   Liu, Jing ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c WUHAN INSTITUTE OF TECHNOLOGY   (China)

Author keywords

Microencapsulation; Tissue engineered dermis; Umbilical cord mesenchymal stromal cells; Vascular endothelial growth factor; Vascularization; Wound healing

Indexed keywords

CHITOSAN; COLLAGEN; VASCULOTROPIN;

ACELLULAR DERMAL MATRIX; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL SKIN; CELL DIFFERENTIATION; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; CROSS LINKING; ENZYME METABOLISM; FREEZING; GENE EXPRESSION REGULATION; IN VITRO GENE TRANSFER; MICROENCAPSULATION; MINIPIG; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN BLOOD FLOW; SKIN DEFECT; SKIN FIBROBLAST; STEM CELL GENE THERAPY; TISSUE ENGINEERED DERMIS; TISSUE ENGINEERING; UMBILICAL CORD MESENCHYMAL STROMAL CELL TRANSPLANTATION; VEGF GENE; WOUND HEALING;

MICROENCAPSULATION; TISSUE-ENGINEERED DERMIS; UMBILICAL CORD MESENCHYMAL STROMAL CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULARIZATION; WOUND HEALING;

ANIMALS; CAPSULES; CELLS, CULTURED; CHITOSAN; COLLAGEN; DERMIS; EXTRACELLULAR MATRIX; FIBROBLASTS; GENE TRANSFER TECHNIQUES; GUIDED TISSUE REGENERATION; HETEROGRAFTS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MESENCHYMAL STROMAL CELLS; MODELS, ANIMAL; NEOVASCULARIZATION, PHYSIOLOGIC; SKIN DISEASES; SKIN TRANSPLANTATION; SWINE; SWINE, MINIATURE; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TRANSGENES; UMBILICAL CORD; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 84892465774     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2013.10.014     Document Type: Article

References (36)

1. Schneider R.K., Anraths J., Kramann R., Bornemann J., Bovi M., Knüchel R., et al. The role of biomaterials in the direction of mesenchymal stem cell properties and extracellular matrix remodelling in dermal tissue engineering. Biomaterials 2010, 31:7948-7959.
2. McNeil S. Progress and opportunities for tissue-engineered skin. Nature 2007, 445:874-880.
3. Han Y.F., Han Y.Q., Pan Y.G., Chen Y.L., Chai J.K. Transplantation of microencapsulated VEGF genetically modified cells improves angiogenesis of implanted xenogeneic acellular dermis on wound. Transplant Proc 2010, 42:1935-1943.
4. Goren A., Dahan N., Goren E., Baruch L., Machluf M. Encapsulated human mesenchymal stem cells: a unique hypoimmunogenic platform for long-term cellular therapy. FASEB J 2010, 24:22-31.
5. Baksh D., Yao R., Tuan R.S. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 2007, 25:1384-1392.
6. Sun L., Wang D., Liang J., Zhang H., Feng X., Wang H., et al. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum 2010, 62:2467-2475.
7. Chai JK, Liang LM, Yang HM, Feng R, Yin HN, Li FY, etal. Preparation of laser micropore porcine acellular dermal matrix for skin graft: an experimental study. Burns. 2007;33:719-725.
8. Zhu Y., Liu T., Song K., Jiang B., Ma X., Cui Z. Collagen-chitosanpolymer as a scaffold for the proliferation of human adipose tissue-derived stem cells. JMater Sci Mater Med 2009, 20:799-808.
9. Liu Z.C., Chang T.M. Artificial cell microencapsulated stem cells in regenerative medicine, tissue engineering and cell therapy. Adv Exp Med Biol 2010, 670:68-79.
10. Han Y., Chai J., Sun T., Li D., Tao R. Differentiation of human umbilical cord mesenchymal stem cells into fibroblasts in vitro. Biochem Biophys Res Commun 2011, 413:561-565.
11. Han Y.F., Sun T.J., Han Y.Q., Tao R., Chai J.K., Xu G., et al. Preparation of microencapsulated VEGF gene-modified human umbilical cord mesenchymal stem cells and in vitro culture. Eur Rev Med Pharmacol Sci 2013, 17:217-223.
12. Sadat S., Gehmert S., Song Y.H., Yen Y., Bai X., Gaiser S., et al. The cardioprotective effect of mesenchymal stem cells is mediated by IGF-I and VEGF. Biochem Biophys Res Commun 2007, 363:674-679.
13. Schneider R.K., Püllen A., Kramann R., Bornemann J., Knüchel R., Neuss S., et al. Long-term survival and characterisation of human umbilical cord-derived mesenchymal stem cells on dermal equivalents. Differentiation 2010, 79:182-193.
14. Chamberlain G., Fox J., Ashton B., Middleton J. Concise review:mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007, 25:2739-2749.
15. Lavik E., Langer R. Tissue engineering: current state and perspectives. Appl Microbiol Biotechnol 2004, 65:1-8.
16. Karahuseyinoglu S., Cinar O., Kilic E., Kara F., Akay G.G., Demiralp D.O., et al. Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells 2007, 25:319-331.
17. Wang H.S., Hung S.C., Peng S.T., Huang C.C., Wei H.M., Guo Y.J., et al. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 2004, 22:1330-1337.
18. Conconi M.T., Burra P., Di Liddo R., Calore C., Turetta M., Bellini S., et al. CD105 (+) cells from Wharton's jelly show in vitro and in vivo myogenic differentiative potential. Int J Mol Med 2006, 18:1089-1096.
19. Salehinejad P., Alitheen N.B., Ali A.M., Omar A.R., Mohit M., Janzamin E., et al. Comparison of different methods for the isolation of mesenchymal stem cells from human umbilical cord Wharton's jelly. In Vitro Cell Dev Biol Anim 2012, 48:75-83.
20. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., et al. Minimal criteria for defining multipotent mesenchymal stromal cells: the International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
21. Hunt T.K., Burke J., Barbul A., Gimbel M.L. Wound healing. Science 1999, 284:1775.
22. Griffiths M., Ojeh N., Livingstone R., Price R., Navsaria H. Survival of Apligraf in acute human wounds. Tissue Eng 2004, 10:1180-1195.
23. Kørbling M., Estrov Z. Adult stern cells for tissue repair-a new therapeutic concept?. NEngl J Med 2003, 349:570-582.
24. Yoshikawa T., Mitsuno H., Nonaka I., Sen Y., Kawanishi K., Inada Y., et al. Wound therapy by marrow mesenchymal cell transplantation. Plast Reconstr Surg 2008, 121:860-877.
25. Ma L., Gao C., Mao Z., Zhou J., Shen J., Hu X., et al. Collagen/chitosan porous scaffolds with improved biostability for skin tissue engineering. Biomaterials 2003, 24:4833-4841.
26. Heimbach D., Luteman A., Burke J., Cram A., Herndon D., Hunt J., et al. Artificial dermis for major burns: a multi-center randomized clinical trial. Ann Surg 1988, 208:313-320.
27. Madeddu P. Therapeutic angiogenesis and vasculogenesis for tissue regeneration. Exp Physiol 2005, 90:315-326.
28. Senger D.R., Ledbetter S.R., Claffey K.P., Papadopoulos-Sergiou A., Peruzzi C.A., Detmar M. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanism involving the ανβ3 integrin, osteopontin, and thrombin. Am J Pathol 1996, 149:293.
29. Cross S.E., Robert M.S. Defining a model to predict the distribution of topically applied growth factors and other solutes in excisional full-thickness wounds. JInvest Dermatol 1999, 112:36-41.
30. Afkhami F., Durocher Y., Prakash S. Investigation of antiangiogenic tumor therapy potential of microencapsulated HEK293 VEGF165b producing cells. JBiomed Biotechnol 2010, 2010:1-7. 10.1155/2010/645610.
31. Zhang X., Wang W., Xie Y., Zhang Y., Wang X., Guo X., et al. Proliferation, viability, and metabolism of human tumor and normal cells cultured in microcapsule. Appl Biochem Biotechnol 2006, 134:61-76.
32. Kirmaz C., Ozbilgin K., Yuksel H., Bayrak P., Unlu H., Giray G., et al. Increased expression of angiogenic markers in patients with seasonal allergic rhinitis. Eur Cytokine Netw 2004, 15:317-322.
33. Liechty K.W., MacKenzie T.C., Shaaban A.F., Radu A., Moseley A.M., Deans R., et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplanttation in sheep. Nat Med 2000, 6:1282-1286.
34. Carmeliet P. VEGF gene therapy: stimulating angiogenesis or angiomagenesis. Nat Med 2000, 6:1102-1103.
35. Zhang H., Zhu S.J., Wang W., Wei Y.J., Hu S.S. Transplantation of microencapsulated genetically modified xenogeneic cells augments angiogenesis and improves heart function. Gene Ther 2008, 15:40-48.
36. Murua A., Orive G., Hernandez R.M., Pedraz J.L. Cryopreservation based on freezing protocols for the long-term storage of microencapsulated myoblasts. Biomaterials 2009, 30:3495-3501.